Evaluation of Treatment Outcomes after Second-Line Treatment Among Adult Patients with Immune Thrombocytopenia

被引：0
|
作者：
Said, Qayyim [1 ]
Lal, Lincy S. [2 ]
Nezami, Brigette [3 ]
Andrade, Katherine [4 ]
Graves, J. Anthony [5 ]
Roy, Anuja [1 ]
Cuker, Adam [6 ,7 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Optum, Missouri City, TX USA
[3] Novartis Pharmaceut, Madison, NJ USA
[4] Optum, Eden Prairie, MN USA
[5] Novartis, One Hlth Plaza, E Hanover, NJ USA
[6] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115197
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3765
引用
收藏
页数：2
相关论文
共 50 条
  • [1] What is the best second-line treatment for immune thrombocytopenia?
    Mahevas, Matthieu
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1267 - 1268
  • [2] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [3] Laparoscopic splenectomy for second-line treatment of immune thrombocytopenia – analysis of 53 patients and current perspectivesLaparoscopic splenectomy for immune thrombocytopenia
    André Costa-Pinho
    Diana Fernandes
    Renato Bessa-Melo
    Marisa Aral
    Luís Graça
    José Costa-Maia
    European Surgery, 2016, 48 : 273 - 277
  • [4] Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study
    Tjonnfjord, Eirik
    Holme, Pal Andre
    Darne, Bernadette
    Khelif, Abderrahim
    Waage, Anders
    Michel, Marc
    Ben Romdhan, Neila
    Ghanima, Waleed
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (03) : 460 - 465
  • [5] Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study
    Podstawka, John
    Wall, Erika
    Bolster, Lauren
    Patterson, Jeffery M.
    Goodyear, M. Dawn
    Rydz, Natalia
    Sun, Haowei L.
    THROMBOSIS RESEARCH, 2022, 220 : 5 - 11
  • [6] Laparoscopic splenectomy for second-line treatment of immune thrombocytopenia - analysis of 53 patients and current perspectives Laparoscopic splenectomy for immune thrombocytopenia
    Costa-Pinho, Andre
    Fernandes, Diana
    Bessa-Melo, Renato
    Aral, Marisa
    Graca, Luis
    Costa-Maia, Jose
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2016, 48 (05): : 273 - 277
  • [7] Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia
    Deshayes, Samuel
    Godeau, Bertrand
    PLATELETS, 2020, 31 (03) : 291 - 299
  • [8] Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment
    Bussel, James B.
    Garcia, Christine A.
    HAEMATOLOGICA, 2022, 107 (09) : 2018 - 2036
  • [9] Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia
    Shimano, Kristin A.
    Neunert, Cindy
    Bussel, James B.
    Klaassen, Robert J.
    Bhat, Rukhmi
    Pastore, Yves D.
    Lambert, Michele P.
    Bennett, Carolyn M.
    Despotovic, Jenny M.
    Forbes, Peter
    Grace, Rachael F.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (06)
  • [10] Second-line therapies in immune thrombocytopenia
    Grace, Rachael F.
    Neunert, Cindy
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 698 - 706
12345